GSK Looks For New Chair To Lead It Through New Strategic Direction
Executive Summary
GSK’s non-exec chairman steps down from the UK firm, just a month after announcing a split that will reshape the company.
You may also be interested in...
Pfizer Consumer Combo Deal Frees Capital For GSK Pharma Investment
Separating out its consumer business in a joint venture with Pfizer will open up investment possibilities for GlaxoSmithKline's pharma and vaccine businesses.
New CFO Mackay Completes Top Table At GSK
CEO Emma Walmsley’s plans to transform the leadership at GSK have advanced again with the appointment of HSBC's Iain Mackay as the firm's new chief financial officer.
Outlook 2023: Market Experts On Importance Of Value, Mental Health In A ‘World On Fire’
Competitive value propositions are a must in 2023 to win guarded consumers’ business. Companies that effectively address mental health and wellbeing needs and appeal to consumers through sustainability initiatives could have an edge in the recessionary environment, experts suggest. Meanwhile, there are concerns about small cosmetics companies and the availability of resources to help them comply with "modernized" federal regulations.